Matches in Wikidata for { <http://www.wikidata.org/entity/Q56765596> ?p ?o ?g. }
- Q56765596 description "article" @default.
- Q56765596 description "im Februar 2012 veröffentlicher wissenschaftlicher Artikel" @default.
- Q56765596 description "wetenschappelijk artikel" @default.
- Q56765596 description "наукова стаття, опублікована в березні 2012" @default.
- Q56765596 description "ലേഖനം" @default.
- Q56765596 name "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r" @default.
- Q56765596 name "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r" @default.
- Q56765596 type Item @default.
- Q56765596 label "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r" @default.
- Q56765596 label "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r" @default.
- Q56765596 prefLabel "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r" @default.
- Q56765596 prefLabel "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r" @default.
- Q56765596 P1433 Q56765596-56467A68-EF10-4B7C-BCBD-D65293262159 @default.
- Q56765596 P1476 Q56765596-18F54443-10B9-4076-A5EA-903FB1D6ACFA @default.
- Q56765596 P2093 Q56765596-151AF9EE-C094-4949-A34E-4347C69BAC2C @default.
- Q56765596 P2093 Q56765596-16B457F9-6512-441B-A481-D6A1C7C6EB76 @default.
- Q56765596 P2093 Q56765596-1F164FC1-18D7-436E-9E4C-18BB45477431 @default.
- Q56765596 P2093 Q56765596-3EEBB0BE-E71C-43FE-B52F-CC773135701F @default.
- Q56765596 P2093 Q56765596-443484B0-C84B-412E-A51E-8290A58F4167 @default.
- Q56765596 P2093 Q56765596-4542BEA7-E6D4-498B-8422-97940E1F9EE2 @default.
- Q56765596 P2093 Q56765596-4BB77D3C-011E-4D38-B22D-BD33BB009B1F @default.
- Q56765596 P2093 Q56765596-5873A7AC-3C89-4030-ADB5-695A5110BA54 @default.
- Q56765596 P2093 Q56765596-6220C5EC-E43A-4C28-A257-47A021FEA9BF @default.
- Q56765596 P2093 Q56765596-72C06EEE-DDA6-44C6-BD9E-6F07836010AF @default.
- Q56765596 P2093 Q56765596-80FB9660-7E7F-4449-916D-34EBAFFF144D @default.
- Q56765596 P2093 Q56765596-88D442AA-ACE8-4107-8F68-6E31E79275D3 @default.
- Q56765596 P2093 Q56765596-8FCC669A-3503-4B10-9ED1-DC2ABF03B67D @default.
- Q56765596 P2093 Q56765596-A6BC821D-664D-47AA-A8C5-99EEFC67760F @default.
- Q56765596 P2093 Q56765596-CCCF5CC9-7607-4C42-ABF9-B0E54E78FCD1 @default.
- Q56765596 P2093 Q56765596-D66510BF-BA12-4DA6-88F4-7707B0A6EA6C @default.
- Q56765596 P2093 Q56765596-EF4A5112-3A8B-4E5C-9AAD-52259F7574F1 @default.
- Q56765596 P2860 Q56765596-24C8DCAC-C146-46CE-A804-99B1566BA7DD @default.
- Q56765596 P2860 Q56765596-2DD25506-79CC-432C-A199-FA319338ED82 @default.
- Q56765596 P2860 Q56765596-49D00C04-B1A1-4EEC-A192-9078CAD0078C @default.
- Q56765596 P2860 Q56765596-4EC613CD-356B-4DB3-8BA0-DB2A8E37ED6E @default.
- Q56765596 P2860 Q56765596-5D5DAB3D-110D-410E-99F7-482CEB707BBF @default.
- Q56765596 P2860 Q56765596-6717F692-B777-4115-BA41-10EB438A2C61 @default.
- Q56765596 P2860 Q56765596-686E6BD8-B79A-47B5-85A1-766244E7F0F6 @default.
- Q56765596 P2860 Q56765596-6ABF3603-2C2D-4ADC-909B-F84044A1B7FF @default.
- Q56765596 P2860 Q56765596-71F4BFC5-8BCB-44D1-A9A0-3889AB3C2F58 @default.
- Q56765596 P2860 Q56765596-752F8C56-8611-4107-A784-8486BFB8F814 @default.
- Q56765596 P2860 Q56765596-832C371B-5C6F-4D36-B4AF-BD84A7141555 @default.
- Q56765596 P2860 Q56765596-8EB6F53F-E08C-4180-9548-E4E346641A7D @default.
- Q56765596 P2860 Q56765596-A630541F-A39E-49E3-A19B-816F4767702B @default.
- Q56765596 P2860 Q56765596-C5159D8C-EB4C-4834-A9C1-A667A66F79DB @default.
- Q56765596 P2860 Q56765596-D443FC72-F3FB-4928-A955-4F2EE702F1FD @default.
- Q56765596 P2860 Q56765596-D4875D4A-944F-4FBD-95E1-5EA7D11CFE01 @default.
- Q56765596 P2860 Q56765596-DBF87667-0673-40B8-8B26-A038E547C8F3 @default.
- Q56765596 P2860 Q56765596-DE481F56-18FA-4A97-A4E3-D0C810ACD8CB @default.
- Q56765596 P2860 Q56765596-F555D1B7-BE2C-4D69-B26F-DE159A4D242C @default.
- Q56765596 P2860 Q56765596-F7AA6058-2618-4438-B8AD-C2758ADEBE2D @default.
- Q56765596 P2860 Q56765596-F7FC2877-859E-41D8-879F-DB10F234738A @default.
- Q56765596 P304 Q56765596-3076AB88-94FE-4A9F-A716-0EFCEEACEDDB @default.
- Q56765596 P31 Q56765596-4FC06F2A-C741-45E0-9B3F-5FFBAE00B9FC @default.
- Q56765596 P356 Q56765596-297D57D3-7B93-42B0-995A-78013841D50D @default.
- Q56765596 P433 Q56765596-54A60AAA-EBF0-41EC-8B91-D8EC4C93C549 @default.
- Q56765596 P478 Q56765596-D55AA568-9252-417D-99C4-D3816464DCD9 @default.
- Q56765596 P50 Q56765596-0DD1D98C-23A6-43EF-AEBF-4F7912428E5F @default.
- Q56765596 P577 Q56765596-C41D1273-F974-44C9-88E0-2D4A2ADD3BA2 @default.
- Q56765596 P698 Q56765596-622B820F-C186-435B-AFA7-A1721720ED49 @default.
- Q56765596 P921 Q56765596-19F301AA-9C35-4DCC-8DFB-6581D286977B @default.
- Q56765596 P921 Q56765596-465E9993-A812-4ABE-AC95-9133E91D9D6E @default.
- Q56765596 P921 Q56765596-4F59EDBF-5880-4857-8E44-D3BFF2215D03 @default.
- Q56765596 P356 S1470-2045(12)70063-3 @default.
- Q56765596 P698 22341744 @default.
- Q56765596 P1433 Q13747613 @default.
- Q56765596 P1476 "Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial" @default.
- Q56765596 P2093 "Annamaria H Zimmermann" @default.
- Q56765596 P2093 "Carla Visseren-Grul" @default.
- Q56765596 P2093 "Cesare Gridelli" @default.
- Q56765596 P2093 "Eckart Laack" @default.
- Q56765596 P2093 "Filippo de Marinis" @default.
- Q56765596 P2093 "Jean-Louis Pujol" @default.
- Q56765596 P2093 "Jesús Corral" @default.
- Q56765596 P2093 "Luis Paz-Ares" @default.
- Q56765596 P2093 "Martin Reck" @default.
- Q56765596 P2093 "Michael Thomas" @default.
- Q56765596 P2093 "Mircea Dediu" @default.
- Q56765596 P2093 "Nadia Chouaki" @default.
- Q56765596 P2093 "Olivier Molinier" @default.
- Q56765596 P2093 "Paolo Bidoli" @default.
- Q56765596 P2093 "Symantha Melemed" @default.
- Q56765596 P2093 "Tarini Prasad Sahoo" @default.
- Q56765596 P2093 "William John" @default.
- Q56765596 P2860 Q21261297 @default.
- Q56765596 P2860 Q25938997 @default.
- Q56765596 P2860 Q27860904 @default.
- Q56765596 P2860 Q28278736 @default.
- Q56765596 P2860 Q29396936 @default.
- Q56765596 P2860 Q29547873 @default.
- Q56765596 P2860 Q29619399 @default.
- Q56765596 P2860 Q29620301 @default.
- Q56765596 P2860 Q34121219 @default.
- Q56765596 P2860 Q34547495 @default.
- Q56765596 P2860 Q36348315 @default.
- Q56765596 P2860 Q36899890 @default.
- Q56765596 P2860 Q37394447 @default.
- Q56765596 P2860 Q42073978 @default.
- Q56765596 P2860 Q43056663 @default.
- Q56765596 P2860 Q43274035 @default.